Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2b Trial of Cytisine in Adult Smokers

NCT03709823 is registered in ClinicalTrials.gov with Achieve Life Sciences as lead sponsor.

NCT NCT03709823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03709823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2b Trial of Cytisine in Adult Smokers
Lead sponsor
Achieve Life Sciences
Phase
Phase 2
Overall status
Completed
Start date
November 13, 2018
Completion date
April 23, 2019
Enrollment
254 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation